dc.contributor
Institut Català de la Salut
dc.contributor
[Razavi-Shearer DM, Hall S, Gamkrelidze I] Center for Disease Analysis Foundation, Lafayette, CO, USA. [Kondili LA] National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy. Saint Camillus International University of Health Sciences, Rome, Italy. [Buti M] Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBEREHD del Instituto Carlos III, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Naveira MCM] Communicable Diseases, Environment and Health, World Health Organization Regional Office for Europe, Copenhagen, Denmark
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Razavi-Shearer, Devin
dc.contributor.author
Kondili, Loreta A.
dc.contributor.author
Hall, Samantha
dc.contributor.author
Gamkrelidze, Ivane
dc.contributor.author
Naveira, Marcelo
dc.contributor.author
Buti Ferret, Maria
dc.date.accessioned
2025-11-05T18:22:09Z
dc.date.available
2025-11-05T18:22:09Z
dc.date.issued
2025-11-04T11:59:54Z
dc.date.issued
2025-11-04T11:59:54Z
dc.identifier
Razavi-Shearer DM, Kondili LA, Hall S, Buti M, Gamkrelidze I, Naveira MCM, et al. Estimating the impact of displacement from Ukraine on HBV and HCV prevalence among migrants in the European Union, 2024: a modeling study. Lancet Reg Heal - Eur. 2025 Nov;58:101452.
dc.identifier
http://hdl.handle.net/11351/14010
dc.identifier
10.1016/j.lanepe.2025.101452
dc.identifier
001565656200001
dc.identifier.uri
http://hdl.handle.net/11351/14010
dc.description.abstract
Epidemiology; European Union; Hepatitis B
dc.description.abstract
Epidemiologia; Unió Europea; Hepatitis B
dc.description.abstract
Epidemiología; Unión Europea; Hepatitis B
dc.description.abstract
Background: In countries with low baseline burdens of hepatitis B and C viruses (HBV, HCV), high levels of migration can impact the burden of viral hepatitis. The screening and treatment of migrants requires different methods and sensitivities than broad-based programs. We aimed to estimate the prevalence of HBV and HCV among migrants in EU-27 countries in 2024. The Ukrainian Refugee Crisis was also quantified.
Methods: Using the United Nations 2024 migrant stock data, we estimated the migrant population for each EU-27 country by five-year age and sex cohorts by country of birth. These distributions were multiplied by five-year age and sex prevalence estimates in the country-of-birth models maintained by the Polaris Observatory. The difference between the 2024 and 2020 Ukrainian migrant stock was quantified to estimate the impact of the Ukrainian Refugee Crisis.
Findings: In 2024, there were an estimated 1.73 million (UI: 1.04-2.66 million) migrants living with HBV and 1.03 million (UI: 757,000-1,559,000) living with anti-HCV in the EU-27, corresponding to migrant prevalences of 2.73% (UI: 1.6-4.2%) and 1.53% (UI: 1.2-2.5%) respectively. The Ukrainian Refugee Crisis is estimated to have resulted in an additional 43,000 (UI: 28,700-60,900) migrants living with HBV, and 154,000 (UI: 12,500-202,000) with HCV in the EU-27.
Interpretation: The burden of HBV and HCV among migrants and which communities are most affected in the EU-27 at the national level are vastly heterogeneous. These data provide evidence for policy makers to better understand the burden their community faces so that they can be better poised to develop culturally appropriate materials and outreach. While there is a great deal of uncertainty regarding the number of migrants by country, as well as the prevalence among these groups, this work provides direction towards which groups are most likely impacted at the EU-27 and national level.
dc.description.abstract
John C Martin Foundation.
dc.format
application/pdf
dc.relation
The Lancet Regional Health - Europe;58
dc.relation
https://doi.org/10.1016/j.lanepe.2025.101452
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Virus de l'hepatitis B
dc.subject
Virus de l'hepatitis C
dc.subject
Emigració i immigració
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence
dc.subject
ORGANISMS::Viruses::DNA Viruses::Hepadnaviridae::Orthohepadnavirus::Hepatitis B virus
dc.subject
ORGANISMS::Viruses::Hepatitis Viruses::Hepacivirus
dc.subject
NAMED GROUPS::Persons::Transients and Migrants
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::estadísticas vitales::morbilidad::prevalencia
dc.subject
ORGANISMOS::virus::virus ADN::Hepadnaviridae::Orthohepadnavirus::virus de la hepatitis B
dc.subject
ORGANISMOS::virus::virus de hepatitis::Hepacivirus
dc.subject
DENOMINACIONES DE GRUPOS::personas::transeúntes y migrantes
dc.title
Estimating the impact of displacement from Ukraine on HBV and HCV prevalence among migrants in the European Union, 2024: a modeling study
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
